2019-05-15T14:08:46-05:00 2018-06-30 910189318 MOSS ADAMS LLP 999 THIRD AVENUE SUITE 2800 SEATTLE WA 98104 990 2017-07-01 911019655 BLOODWORKS BLOO 2062926500 921 TERRY AVENUE SEATTLE WA 981041256 ROBERT GLEASON CHIEF FINANCIAL OFFICER 2066896680 2019-05-14 1 COLLEEN RAMIRES P01251320 2063026500 2019-05-14 12.129.7.100 2019-05-14 16:12:34 PD P DA39A3EE5E6B4B0D3255BFEF95601890AFD80709 21D6D88AA253EBC443F9931C9F869B6318C08854 2017 2019-02-21 02:37:17Z DR JAMES AUBUCHON 921 TERRY AVENUE SEATTLE WA 981041256 210383916 0 X WWW.BLOODWORKSNW.ORG X 1944 WA SAVING LIVES THROUGH RESEARCH, INNOVATION, EDUCATION & EXCELLENCE IN BLOOD, MEDICAL & LAB SERVICES. 20 19 1137 1837 0 165153 1421459 1034605 175947671 194400628 14070815 2311050 224538 186025 191664483 197932308 508978 1740182 0 0 75401590 80587370 77421 33328 2943551 105207112 121374187 181195101 203735067 10469382 -5802759 147198662 147232810 48339588 54054758 98859074 93178052 SAVING LIVES THROUGH RESEARCH, INNOVATION, EDUCATION AND EXCELLENCE IN BLOOD, MEDICAL AND LABORATORY SERVICES IN PARTNERSHIP WITH OUR COMMUNITY. 0 0 166116222 116051 184983291 RECRUIT DONORS, COLLECT, TEST, PROCESS AND FRACTIONATE WHOLE BLOOD AND COMPONENTS INTO TRANSFUSION READY PRODUCTS (WHOLE BLOOD, RED BLOOD CELLS, PLATELETS, PLASMA AND CRYOPRECIPITATE) FOR USE IN NEARLY 90 HOSPITALS IN THE PACIFIC NORTHWEST (WESTERN WASHINGTON AND OREGON). 13797212 1624131 9417337 WE ARE A RESEARCH INSTITUTE WITH OVER 70 YEARS OF RESEARCH AND DISCOVERIES. BLOODWORKS SCIENTISTS HAVE TRANSFORMED PATIENT CARE WITH BREAKTHROUGHS IN TRANSFUSION MEDICINE, BLOOD BIOLOGY, BLOOD STORAGE, CANCER THERAPIES, ORGAN TRANSPLANTATION, AND TREATMENT OF CLOTTING DISORDERS. TODAY, OUR STAFF OF 70 SCIENTISTS ACROSS 11 LABORATORIES CONTINUES TO SEARCH FOR NEW KNOWLEDGE AND NEW TECHNOLOGIES TO IMPROVE PATIENT CARE. BLOODWORKS' SCIENTISTS CAN BE FOUND IN MEDICAL SCHOOLS AND AT SCIENTIFIC FORUMS SHARING THE LATEST BLOOD SCIENCE WITH DOCTORS FROM AROUND THE REGION - AND AROUND THE WORLD. 179913434 1 1 0 1 0 0 0 0 0 1 1 0 0 0 0 1 1 0 0 1 1 1 0 1 1 0 0 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 217 0 1 1137 1 1 1 0 0 0 0 1 1 0 0 0 0 0 X 20 19 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 1 0 WA OR X ROBERT GLEASON 2066896680 921 TERRY AVENUE SEATTLE WA 981041256 HOLLI HARRIS BOARD CHAIR 1.00 X X 0 0 0 BILL BALDWIN BOARD VICE-CHAIR (THROUGH 5/18) 1.00 X X 0 0 0 CRAIG SMITH MD BOARD VICE-CHAIR 1.00 X X 0 0 0 DAVID CHICHESTER BOARD TRUSTEE 1.00 X 0 0 0 ANNE DAFFERN BOARD TRUSTEE 1.00 X 0 0 0 MOLLY FIRTH BOARD TRUSTEE 1.00 X 0 0 0 PAT FORCE BOARD TRUSTEE 1.00 X 0 0 0 CARLA FOWLER MD PHD BOARD TRUSTEE 1.00 X 0 0 0 JIM GARRISON BOARD TRUSTEE 1.00 X 0 0 0 HUNTER GRAHAM GOODMAN JD BOARD TRUSTEE 1.00 X 0 0 0 BILL HAMMOND MD BOARD TRUSTEE 1.00 X 0 0 0 CRAIG HENDRICKSON BOARD TRUSTEE 1.00 X 0 0 0 W CONRAD LILES MD PHD BOARD TRUSTEE 1.00 X 0 0 0 MEREDITH MATHEWS MD BOARD TRUSTEE 1.00 X 0 0 0 JIM PALMERI BOARD TRUSTEE 1.00 X 0 0 0 SEAN W SIGMON BOARD TRUSTEE 1.00 X 0 0 0 CRAIG M TREWET BOARD TRUSTEE 1.00 X 0 0 0 PHYLLIS T TURNER-BRIM ESQ BOARD TRUSTEE 1.00 X 0 0 0 BOB WALLACE BOARD TRUSTEE 1.00 X 0 0 0 GLENN WISEGARVER BOARD TRUSTEE 1.00 X 0 0 0 JAMES AUBUCHON MD PRESIDENT & CEO 40.00 X X 793983 0 37420 ROBERT GLEASON TREASURER & CFO 40.00 X 253164 0 51928 MAXINE SELLERS SECRETARY 40.00 X 69889 0 17183 LINDA S BARNES CHIEF OPERATING OFFICER 40.00 X 323786 0 37177 KARYN L DENTON VICE PRESIDENT CLINICAL SERVICES 40.00 X 193558 0 30896 CHRISTINE DONATELLI CHIEF QUALITY & CORP COMPLIANCE OFF. 40.00 X 213692 0 35132 SANDRA LINAUTS THROUGH 817 VICE PRESIDENT BLOOD SERVICES 40.00 X 362843 0 32445 KAREN NELSON VP SPECIALTY LABORATORIES 40.00 X 165850 0 25517 YANYUN WU MD CHIEF MEDICAL OFFICER 40.00 X 362820 0 14114 JAMES C ZIMRING MD CHIEF SCIENTIFIC OFFICER 40.00 X 386896 0 30878 JOSE A LOPEZ MD RESEARCHER 40.00 X 308056 0 39014 SHERRIL J SLICHTER MD MEDICAL DIRECTOR 40.00 X 300413 0 33410 BARBARA A KONKLE MD MEDICAL DIRECTOR 40.00 X 314351 0 26825 KIRSTEN W ALCORN MD MEDICAL DIRECTOR 40.00 X 280692 0 26514 REBECCA KRUSE-JARRES MD MEDICAL DIRECTOR 40.00 X 248305 0 20644 THERESA A NESTER CLINICAL CONS. (FORMER KEY EMPLOYEE) 40.00 X 228348 0 31558 4806646 0 490655 106 1 1 0 BN BUILDERS INC 2601 4TH AVENUE SUITE 350 SEATTLE WA 98121 CONSTRUCTION SERVICES 1225903 NUWEST GROUP HOLDINGS LLC PO BOX 40285 BELLEVUE WA 98015 TEMPORARY HELP 857556 DEGREE 37 LLC 14594 NW TREE TOP LANE SEABECK WA 98380 CONSULTANTS 769613 NINE75 LLC 1001 FOURTH AVENUE SUITE 4500 SEATTLE WA 98154 CONSULTANTS 743980 MEDIA PLUS 160 ROY STREET SEATTLE WA 98109 MARKETING 489838 37 352930 681675 96 1034605 SERVICE FEES 541900 108058136 108058136 BLOOD DERIVATIVES 339110 74581108 74581108 RESEARCH REVENUE 541700 9417337 9417337 DELIVERY FEES 480000 420831 420831 JOINT VENTURE INVESTMENT 621500 143335 143335 1779881 1779881 194400628 1494804 1494804 1367313 1146765 220548 220548 220548 11830389 81429 10948087 147485 882302 -66056 816246 816246 174748 352930 209271 -34523 -34523 197932308 194400628 0 2497075 1484088 1484088 204033 204033 52061 52061 3467835 976304 2491531 60224178 50756616 8243148 1224414 4293489 3330409 942698 20382 7475757 6190550 1138406 146801 5126111 4177996 849249 98866 340974 212859 128115 120000 120000 134534 134534 33328 33328 304489 304489 6693431 5483800 428234 781397 1984889 1081428 750927 152534 2721077 2098877 575417 46783 4113494 3316273 720496 76725 6819756 5440398 1235796 143562 788426 472037 269304 47085 238101 105673 130276 2152 874111 9009 859462 5640 6382192 5127524 1123835 130833 787650 638554 133549 15547 DRUGS & SUPPLIES 86072319 86072319 TRANSPORTATION 2735801 2419683 298616 17502 PROVISION FOR BAD DEBT 198953 198953 63990 63990 203735067 179913434 20878082 2943551 29218 0 4883104 2107637 2446897 3051231 21420692 25825218 2422739 2770299 2620905 2600695 140448988 90403858 50258810 50045130 61957565 59348853 40641 40641 1118091 1443106 147198662 147232810 26758004 33464921 21581584 20589837 48339588 54054758 X 93885994 88393487 1418831 1468716 3554249 3315849 98859074 93178052 147198662 147232810 X -5802759 265072 -143335 X 0 1 X 1 1 1 X 1259917 11548534 1510536 1421459 1034605 16775051 159648812 161263038 175586838 174503908 194400628 865403224 212351 200510 181353 184651 174748 953613 161121080 173012082 177278727 176110018 195609981 883131888 72760 6879157 502912 276559 223000 7954388 1242940 1242940 72760 8122097 502912 276559 223000 9197328 873934560 3162201 2693945 2636355 2937686 2862117 14292304 3162201 2693945 2636355 2937686 2862117 14292304 164283281 175706027 179915082 179047704 198472098 897424192 0.97380 0.97290 0.01590 0.01650 X 1 1 0 1 25172 1 19707 0 1 73787 0 1 39122 157788 0 PART II-B, LINE 1: DURING FISCAL YEAR 2018 A GROUP OF BLOODWORKS EMPLOYEES SPENT A DAY IN OLYMPIA GETTING TO KNOW THEIR WA STATE LEGISLATORS. THE CEO SPENDS TIME STAYING CURRENT ON WA STATE LEGISLATIVE CHANGES THAT AFFECT HEALTH CARE. IN 2016 BLOODWORKS WORKED WITH THE WA LEGISLATURE TO GET SIGNED INTO LAW A REGISTRATION REQUIREMENT WITH THE WA DEPARTMENT OF HEALTH FOR ENTITIES WHO WERE COLLECTING BLOOD. THE INTENT WAS TO MAKE ALL ENTITIES COLLECTING BLOOD SUBJECT TO THE SAME STRINGENT LICENSURE IMPOSED BY THE FDA THAT BLOOD BANKS MUST FOLLOW. THIS BILL PASSED DURING THE 2016 LEGISLATIVE SESSION. ON JUNE 23, 2017, THE DEPARTMENT OF HEALTH ADOPTED A RULE THAT WOULD CHANGE THE LEGISLATIVE INTENT OF SHB 2580 BY ALLOWING HOSPITALS TO BE EXEMPT FROM THE FDA LICENSURE REQUIREMENT. IN 2018 BLOODWORKS CHALLENGED THE RULING. THERE WERE CONSULTING AND ATTORNEY'S FEES ASSOCIATED WITH THE CHALLENGE. 3800128 -238400 100678 3662406 3625990 8500 165638 3800128 3581374 3545 41071 3625990 446312 3104500 33444 2882 3581374 437267 3400 43322 35416 2261 446312 0.00000 0.90540 0.09460 0 0 2918261 2918261 43275498 24212464 19063034 24751159 14448009 10303150 57026821 46172173 10854648 12477249 5571212 6906037 50045130 X 199105592 265072 96 265168 198840424 304489 -1212605 -908116 197932308 204786614 96 1355940 1356036 203430578 304489 304489 203735067 PART V, LINE 4: INTENDED USE OF ENDOWMENT FUND EARNINGS IS FOR MEDICAL RESEARCH AS WELL AS AN ANNUAL LECTURE SERIES. PART X, LINE 2: THE ORGANIZATION IS A NOT-FOR-PROFIT CORPORATION AND HAS BEEN RECOGNIZED AS TAX-EXEMPT PURSUANT TO SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE. THE ORGANIZATION IS EXEMPT FROM FEDERAL INCOME TAX UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE EXCEPT TO THE EXTENT OF UNRELATED BUSINESS TAXABLE INCOME AS DEFINED UNDER IRC SECTIONS 511 THROUGH 515. ANY UNRELATED BUSINESS INCOME GENERATED IS NOT SIGNIFICANT; THEREFORE, NO PROVISION FOR INCOME TAXES HAS BEEN RECORDED. THE ORGANIZATION HAS ADOPTED ACCOUNTING FOR UNCERTAIN TAX POSITIONS. THE ACCOUNTING STANDARDS PRESCRIBES A RECOGNITION THRESHOLD AND MEASUREMENT PROCESS FOR UNCERTAIN TAX POSITIONS. AS OF JUNE 30, 2018 AND 2017, THE ORGANIZATION HAD NO UNCERTAIN TAX POSITIONS REQUIRING ACCRUAL. PART XI, LINE 4B - OTHER ADJUSTMENTS: RENTAL EXPENSES NETTED WITH RENTAL REVENUE -1,146,765. FUNDRAISING FEES NETTED WITH FUNDRAISING REVENUE -209,175. JOINT VENTURE INVESTMENT BOOK/TAX ADJUSTMENT 143,335. PART XII, LINE 2D - OTHER ADJUSTMENTS: RENTAL EXPENSES NETTED WITH RENTAL REVENUE 1,146,765. FUNDRAISING FEES NETTED WITH FUNDRAISING REVENUE 209,175. 1 SUB-SAHARAN AFRICA 0 0 PROGRAM SERVICES TRAVEL TO TEACH SAFE BLOOD TECHNIQUES AND INSTITUTE RESEARCH STUDIES 59655 NORTH AMERICA (CANADA AND MEXICO) 0 0 PROGRAM SERVICES & GRANTMAKING TRAVEL TO TEACH SAFE BLOOD TECHNIQUES AND INSTITUTE RESEARCH STUDIES 52561 EUROPE (INCLUDING ICELAND AND GREENLAND) 0 0 PROGRAM SERVICES BLOOD GROUP GENOTYPING REFERENCE PANEL 1190 NORTH AMERICA (CANADA AND MEXICO) 0 0 PROGRAM SERVICES GENETIC TESTING 2645 0 0 0 0 0 0 116051 0 116051 NORTH AMERICA (CANADA AND MEXCIO) SUPPORT FOR SICKLE CELL DISEASE PATHOPHYSIOLOGY 52061 CHECK 1 0 0 0 0 0 0 0 PART I, LINE 2: PROCEDURES FOR MONITORING THE USE OF GRANTS AND OTHER ASSISTANCE OUTSIDE THE UNITED STATES INCLUDE REVIEW OF THE SUBRECIPIENT'S FINANCIAL AUDIT AND FOLLOW UP, IF NEEDED, ON ANY FINDINGS. ADDITIONALLY, THERE IS A PROCESS TO REVIEW GENERAL LEDGERS AND WORK CLOSELY WITH THE FINANCIAL DEPARTMENT OF THE SUBRECIPIENT TO ENSURE THAT EXPENSES, INCLUDING SALARY EFFORTS, ARE REASONABLE, PRUDENT, WITHIN THE TERMS OF THE AGREEMENT AND COMPLIANT WITH FEDERAL GUIDELINES. PART I, LINE 3: ASSESSING THE ROLE OF IMPROVED PRE-TRANSFUSION TESTING IN THE PREVENTION OF ALLOIMMUNIZATION IN HAEMOLYTIC TRANSFSION REACTIONS AMONG UGANDANS. X X X X X X X 1 DEL PRODO PHILANTHROPY TRAINING & CONSULTING LLC 5330 89TH AVE SE MERCER ISLAND WA 98040 SEE PART IV 0 0 33328 -33328 33328 -33328 WA OR BLOODWORKS BALL 465506 321242 144264 4703 79422 23315 82983 SWIM FOR LIFE 62172 31688 30484 96 18752 527678 352930 174748 96 4703 79422 23315 101735 209271 -34523 PART I, LINE 2B: DEL PRODO PHILANTHROPY TRAINING & CONSULTING LLC - CONSULTING WORK TO FUNDRAISE WITHIN CORPORATE PHILANTHROPY. 1 TERUMO BCT INC 10811 W COLLINS AVE LAKEWOOD CO 80215 841155788 501(C)(3) 394681 ARMY PREPS (US ARMY MEDICAL RESEARCH ACQUISITION ACT) UNIVERSITY OF WASHINGTON 4333 BROOKLYN AVENUE NE SEATTLE WA 98195 916001537 PUBLIC UNIVERSITY 168581 SEE PART IV BAYLOR COLLEGE OF MEDICINE ONE BAYLOR PLAZA HOUSTON TX 770303411 741613878 501(C)(3) 104523 MOLECULAR BIOLOGY, ETHNIC DIVERSITY AND DISEASE ASSOCIATIONS UNIVERSITY OF COLORADO 13001 E 17TH PLACE BLDG 500 AURORA CO 80045 846000555 PUBLIC UNIVERSITY 21531 BIOSYNTHETIC AND FUNCTIONAL CONSEQUENCES OF VON WILLEBRAND DISEASE MUTATIONS UNIVERSITY OF VIRGINIA PO BOX 400195 CHARLOTTESVILE NC 22904 546001796 PUBLIC UNIVERSITY 79973 SERIOUS HAZARDS OF TRANSFUSION & CELLULAR THERAPIES: MECHANISMS & INTERVENTION YALE UNIVERSITY 25 SIENE PARK - 3RD FLOOR 100 MUNSON NEW HAVEN CT 065208327 060646973 501(C)(3) 183006 IMMUNOBIOLOGY OF TRANSFUSION PROVIDENCE HEALTH & SERVICES 101 WEST 8TH AVENUE SPOKANE WA 99204 510216586 501(C)(3) 26400 COMPARISON OF IDEAL VS ACTUAL WEIGHT BASE FACTOR DOSING OREGON HEALTH SCIENCES UNIVERSITY 3181 SW SAM JACKSON PARK ROAD PORTLAND OR 97239 931176109 PUBLIC UNIVERSITY 60965 COMPARISON OF IDEAL VS ACTUAL WEIGHT BASE FACTOR DOSING EMORY UNIVERSITY 1599 CLIFTON RD NE 4TH FLOOR ATLANTA GA 30322 580566256 501(C)(3) 139831 IMMUNOBIOLOGY OF TRANSFUSION RECTOR & VISITORS OF THE UNIVERSITY PO BOX 400195 CHARLOTTESVILE NC 22904 546001796 501(C)(3) 200475 IMMUNOBIOLOGY OF TRANSFUSION 9 1 RESEARCH PARTICIPANTS FOR BLOOD STUDIES 500 204033 PART I, LINE 2: MONITORING/REVIEW/PROCEDURES: PRIOR TO ISSUING A SUBAWARD, BLOODWORKS REVIEWS THE ENTITY ON WWW.SAM.GOV FOR DEBARMENT OR SUSPENSION FROM RECEIVING FEDERAL FUNDS AND CONFIRMS THE CCR STANDING OF THE ENTITY. GRANT AND CONTRACTS SPECIALIST REVIEWS THIS INFORMATION ANNUALLY. IN ADDITION, BLOODWORKS RECEIVES AND REVIEWS THE ANNUAL OMB SINGLE AUDIT FOR OUR SUBRECIPIENTS AND ADDRESSES ANY FINDINGS FROM THE AUDIT. THE SUBAWARD IDENTIFIES THE MAXIMUM AMOUNT OF AWARD AND BLOODWORKS STAFF VERIFIES THAT THE PAYMENTS DO NOT EXCEED THIS AMOUNT. SUBRECIPIENTS ARE SELECTED BASED ON THE NEEDS OF THE AWARD AND WHICH ORGANIZATION IS ABLE TO BEST PARTNER WITH THE PRINCIPAL INVESTIGATOR. PART II, LINE 1: UNIVERSITY OF WASHINGTON GRANTS: 1. CLINICAL EFFECTIVENESS OF STANDARD VS MIRASOL-TREATED APHERESIS PLATELETS IN PATIENTS WITH HYPOPROLIFERATIVE THROMBOCYTOPENIA. 2. NATIONAL HEMOPHILIA MUTATION ANALYSIS PROJECT. 3. BIOSYNTHETIC AND FUNCTIONAL CONSEQUENCES OF VON WILLEBRAND DISEASE MUTATIONS. 4. ASSESS THE USE OF NAC IN PATIENTS WITH SICKLE CELL DISEASE. 5. LIFE SCIENCES DISCOVERY FUND - INTEGRATED CHIP-SCALE BLOOD TESTING FOR TRANSFUSION MEDICINE. X X 1 1 X X X X 1 1 0 0 0 0 0 1 0 JAMES AUBUCHON MD PRESIDENT & CEO 667609 0 0 0 126374 0 18900 0 18520 0 831403 0 0 0 ROBERT GLEASON TREASURER & CFO 253164 0 0 0 0 0 26475 0 25453 0 305092 0 0 0 LINDA S BARNES CHIEF OPERATING OFFICER 323786 0 0 0 0 0 13500 0 23677 0 360963 0 0 0 KARYN L DENTON VICE PRESIDENT CLINICAL SERVICES 193558 0 0 0 0 0 13962 0 16934 0 224454 0 0 0 CHRISTINE DONATELLI CHIEF QUALITY & CORP COMPLIANCE OFF. 213692 0 0 0 0 0 11455 0 23677 0 248824 0 0 0 SANDRA LINAUTS THROUGH 817 VICE PRESIDENT BLOOD SERVICES 160949 0 0 0 201894 0 27000 0 5445 0 395288 0 0 0 KAREN NELSON VP SPECIALTY LABORATORIES 165850 0 0 0 0 0 16707 0 8810 0 191367 0 0 0 YANYUN WU MD CHIEF MEDICAL OFFICER 362820 0 0 0 0 0 13500 0 614 0 376934 0 0 0 JAMES C ZIMRING MD CHIEF SCIENTIFIC OFFICER 336448 0 50448 0 0 0 17876 0 13002 0 417774 0 0 0 JOSE A LOPEZ MD RESEARCHER 308056 0 0 0 0 0 27000 0 12014 0 347070 0 0 0 SHERRIL J SLICHTER MD MEDICAL DIRECTOR 300413 0 0 0 0 0 27000 0 6410 0 333823 0 0 0 BARBARA A KONKLE MD MEDICAL DIRECTOR 314351 0 0 0 0 0 18900 0 7925 0 341176 0 0 0 KIRSTEN W ALCORN MD MEDICAL DIRECTOR 280692 0 0 0 0 0 13500 0 13014 0 307206 0 0 0 REBECCA KRUSE-JARRES MD MEDICAL DIRECTOR 248305 0 0 0 0 0 12542 0 8102 0 268949 0 0 0 THERESA A NESTER CLINICAL CONS. (FORMER KEY EMPLOYEE) 228348 0 0 0 0 0 23456 0 8102 0 259906 0 0 0 PART I, LINE 1A FIRST CLASS TRAVEL IS PROVIDED TO THE PRESIDENT UNDER VERY SPECIFIC AND APPROVED CIRCUMSTANCES. SOCIAL CLUB DUES WERE PROVIDED FOR THE PRESIDENT. SOCIAL CLUBS ARE USED FOR BUSINESS RELATED MEETINGS. PART I, LINES 4A-B SCHEDULE J, PART I, LINE 4A: SANDRA LINAUTS RECEIVED A SEVERANCE PAYMENT FOR $201,894 IN 2017. SCHEDULE J, PART I, LINE 4B: BLOODWORKS HAS A SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN ESTABLISHED TO PROVIDE ADDITIONAL RETIREMENT COMPENSATION TO DR. JAMES AUBUCHON, PRESIDENT AND CEO. AS OF SEPTEMBER 2015 DR. AUBUCHON WAS FULLY VESTED IN THE PLAN. FOR THE CURRENT YEAR, DR. AUBUCHON RECEIVED A DISTRIBUTION OF $126,374 FROM THE PLAN. PART I, LINE 7 THE BOARD DETERMINES AND APPROVES THE BONUSES FOR THE CEO, DR. AUBUCHON. IF APPLICABLE OTHER EMPLOYEE BONUSES ARE CONTRACTUALLY DRIVEN BY THE TERMS OF THEIR EMPLOYMENT AGREEMENTS. HUMAN RESOURCES REVIEWS AND MAINTAINS EMPLOYMENT AGREEMENTS. DR. AUBUCHON'S BONUS IS AT THE DISCRETION OF THE BOARD. A WA ECONOMIC DEVELOPMENT FINANCE AUTHORITY 911493002 2014-09-15 24140000 PURCHASE AND RENOVATION OF RENTON, WA FACILITY 0 0 0 A 3550162 24140000 209442 23930558 2009 1 0 1 1 A 0 1 1 1 0 0 0 1 A 0 1 0 0 1 0 0 0 1 A 1 PART II, LINE 14 THE PURPOSE OF THIS BOND WAS TO PROVIDE FUNDS FOR A REFUNDING OF BONDS ISSUED AUGUST 14, 2008. FORM 990, PART VI, SECTION B, LINE 11B INTERNALLY, DATA FOR THE FORM 990 IS PREPARED BY THE ACCOUNTING DEPARTMENT AND REVIEWED BY THE CONTROLLER AND THE CHIEF FINANCIAL OFFICER. THE FORM 990 IS THEN PREPARED BY OUR CPA FIRM. EXTERNAL REVIEW CONSISTS OF THE FORM 990 BEING POSTED TO THE BOARD OF TRUSTEES WEBSITE, AND THE BOARD MEMBERS ARE EMAILED A LINK TO THIS PASSWORD PROTECTED SITE SO THAT THE FORM 990 CAN BE REVIEWED. FORM 990, PART VI, SECTION B, LINE 12C BLOODWORKS HAS ALL HUMAN RESOURCE POLICIES (INCLUDING CONFLICT OF INTEREST) ONLINE AND ACCESSIBLE. ANY CHANGES ARE HIGHLIGHTED AND SENT TO ALL EMPLOYEES. UPON HIRE AND UPON MAJOR POLICY CHANGES, EMPLOYEE SIGNS ACKNOWLEDGEMENT FORM TO EVIDENCE THAT SHE/HE IS RESPONSIBLE TO READ AND BECOME ACQUAINTED WITH THE POLICIES. ANNUALLY BOARD MEMBERS MUST SIGN A FORM AND DISCLOSE CONFLICTS OF INTEREST. THESE ARE REVIEWED BY THE BOARD CHAIR AND PRESIDENT. IF A CONFLICT OF INTEREST EXISTS, AN INTERESTED PERSON MAY MAKE A PRESENTATION, BUT MUST LEAVE THE MEETING DURING ANY DISCUSSION OF THE MATTER. THE CHAIRPERSON MAY, IF APPROPRIATE, APPOINT A DISINTERESTED PERSON TO INVESTIGATE ALTERNATIVES. THE BOARD OR COMMITTEE SHALL EXERCISE DUE DILIGENCE TO DETERMINE WHETHER THE ORGANIZATION CAN OBTAIN WITH REASONABLE EFFORTS A MORE ADVANTAGEOUS TRANSACTION OR ARRANGEMENT THAT DOES NOT CREATE A CONFLICT OF INTEREST. FORM 990, PART VI, SECTION B, LINE 15 THE EXECUTIVE COMMITTEE OF THE BOARD REVIEWS AND APPROVES THE PRESIDENT'S COMPENSATION BASED ON RESEARCH OF OTHER COMPARABLE ORGANIZATIONS AND INDUSTRY STANDARDS PERFORMED BY A COMPENSATION CONSULTING FIRM. IN 2017 AN OUTSIDE CONSULTING FIRM PROVIDED TRENDS IN BOTH PERFORMANCE INCREASES AND BONUSES FOR CEOS. THE BOARD USED THIS INFORMATION IN THE PRESIDENT'S COMPENSATION REVIEW. KEY EMPLOYEE AND OFFICER SALARIES ARE REVIEWED AGAINST MARKET DATA WITH CONSIDERATION OF INTERNAL EQUITY. MARKET DATA INCLUDES ANNUAL SURVEY FROM INDUSTRY ASSOCIATION AND COMPARISON TO ADDITIONAL REGIONAL AND NATIONAL MARKET DATA APPROXIMATELY EVERY TWO TO THREE YEARS. IN ADDITION, MEDICAL STAFF SALARIES ARE REVIEWED AGAINST UNIVERSITY RANGES FOR PHYSICIANS OF LIKE SPECIALTIES. FORM 990, PART VI, SECTION C, LINE 19 GOVERNING DOCUMENTS AND AUDITED FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST. BLOODWORKS HAS ALL HUMAN RESOURCE POLICIES (INCLUDING CONFLICT OF INTEREST) ONLINE AND ACCESSIBLE. FORM 990, PART XI, LINE 9: JOINT VENTURE INVESTMENT BOOK/TAX ADJUSTMENT -143,335.